Provided by Tiger Trade Technology Pte. Ltd.

XOMA Corp

27.04
+1.726.79%
Volume:196.72K
Turnover:5.28M
Market Cap:334.84M
PE:36.05
High:27.39
Open:25.79
Low:25.59
Close:25.32
52wk High:39.92
52wk Low:18.35
Shares:12.38M
Float Shares:9.59M
Volume Ratio:1.43
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7500
EPS(LYR):-1.6488
ROE:22.45%
ROA:1.43%
PB:3.81
PE(LYR):-16.40

Loading ...

XOMA Royalty Is Maintained at Outperform by Leerink Partners

Dow Jones
·
14 hours ago

XOMA Royalty to Present at Investor Conferences in March

GlobeNewswire
·
Feb 19

Analysts Offer Insights on Healthcare Companies: Xoma (XOMA) and Decibel Cannabis Company (OtherDBCCF)

TIPRANKS
·
Feb 14

XOMA Royalty Corp (Pre-Reincorporation) : TD Cowen Reinstates Coverage With Hold Rating

THOMSON REUTERS
·
Feb 13

XOMA Royalty Completes Generation Bio Acquisition and Merger

TIPRANKS
·
Feb 10

XOMA Royalty übernimmt Generation Bio für 4,29 Dollar je Aktie

Reuters
·
Feb 09

XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

THOMSON REUTERS
·
Feb 09

XOMA Royalty Corporation Issues Amendment to Report on LAVA Legacy Assets

Reuters
·
Feb 03

XOMA Royalty Appoints New Chief Financial Officer

TIPRANKS
·
Jan 16

XOMA Royalty Corporation Files Initial Beneficial Ownership Statement for CFO Jeffrey Trigilio

Reuters
·
Jan 15

Xoma announces CFO Burns to step down, Trigilio to succeed

TIPRANKS
·
Jan 12

XOMA Royalty Names Jeffrey Trigilio Finance Chief as Thomas Burns Departs

Dow Jones
·
Jan 12

XOMA Highlights Royalty Growth Strategy in Updated Presentation

TIPRANKS
·
Jan 12

BRIEF-Xoma Royalty Announces CFO Transition

Reuters
·
Jan 12

XOMA Royalty Corp - CFO Thomas Burns Stepping Down

THOMSON REUTERS
·
Jan 12

XOMA Royalty Corp - Appoints Jeffrey Trigilio as CFO

THOMSON REUTERS
·
Jan 12

XOMA Royalty Announces CFO Transition

GlobeNewswire
·
Jan 12

XOMA Royalty Corp - Retains Low Royalty and $13 Mln in Milestones for Mezagitamab

THOMSON REUTERS
·
Dec 30, 2025

XOMA Royalty: Entitled to Payments Associated With Nine Development-Stage Assets Held Within Takeda's Externalized Assets Portfolio

THOMSON REUTERS
·
Dec 30, 2025

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

GlobeNewswire
·
Dec 30, 2025